Quarterly report pursuant to Section 13 or 15(d)

Statements of Operations

v3.21.2
Statements of Operations - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Statements of Operations        
Grant revenue $ 84,705 $ 6,515 $ 326,766 $ 6,515
Cost of grant revenue 84,705 6,515 326,766 6,515
Gross profit     0 0
Operating expenses:        
Research and development 560,693 316,325 821,573 666,989
General and administrative 603,518 515,878 1,204,204 1,095,648
Sales and marketing 112,033   174,611 0
Total operating expenses 1,276,244 832,203 2,200,388 1,762,637
Loss from operations (1,276,244) (832,203) (2,200,388) (1,762,637)
Other expenses:        
Interest expense, net 1,856 1,055 1,862 1,122
Gain on loan forgiveness (91,407)   (91,407) 0
Total other expenses (89,551) 1,055 (89,545) 1,122
Net loss $ (1,186,693) $ (833,258) $ (2,110,843) $ (1,763,759)
Net loss per share - basic and fully diluted $ (0.19) $ (0.28) $ (0.37) $ (0.59)
Weighted average number of shares outstanding - basic and fully diluted (in shares) 6,125,874 2,998,350 5,737,109 2,983,372